Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Manufacturing & engineering

Directa Plus signs €150,000 supply agreement for its graphene nanoplatelets technology

Officine di Cartigliano will be using Directa's G+ formulation to improve the performance of its equipment

Directa Plus PLC (AIM:DCTA, OTC:DTPKF) signed a supply agreement with Officine di Cartigliano for its patented G+ pristine graphene nanoplatelets technology, worth €150,000 over one year on a take or pay basis.

Officine di Cartigliano, an Italian-based producer of tanning equipment for the textile industry, will be using the G+ formulation to improve the performance of its equipment, particularly to address antistatic issues, Directa Plus said in a statement.

Directa is a producer and supplier of graphene nanoplatelets-based products for use in the consumer and industrial market.

Giulio Cesareo, Directa chief executive and founder, commented: "We have the know-how and the product to aid Cartigliano on this technical industrial application.

“Innovation is not just having good ideas but knowing how to transform those ideas into significant business opportunities for our partners."

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK